FCA
COLL icon

Fortis Capital Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Fortis Capital Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$994K Hold
27,467
– – 0.11% 164
2026
Q1 		$908K Buy
27,467
+10,729
+64% +$454K 0.12% 151
2025
Q4 		$775K Buy
16,738
+3,048
+22% +$128K 0.11% 162
2025
Q3 		$479K Hold
13,690
– – 0.08% 183
2025
Q2 		$405K Buy
13,690
+30
+0.2% +$856 0.07% 178
2025
Q1 		$408K Buy
+13,660
New +$417K 0.08% 179
2023
Q2 		– Sell
-40
Closed -$960 – 211
2023
Q1 		$960 Buy
+40
New +$1.06K ﹤0.01% 614

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Fortis Capital Advisors's COLL Position: Q2 2026 in Review

Fortis Capital Advisors held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 27,467 shares worth $994K. The position accounts for 0.11% of the portfolio, ranked #164.

Fortis Capital Advisors first reported a position in COLL in Q1 2023 and has held it in 7 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Fortis Capital Advisors held 27,467 shares of Collegium Pharmaceutical worth $994K as of Q2 2026.
  • Fortis Capital Advisors left its Collegium Pharmaceutical share count unchanged in Q2 2026.
  • Collegium Pharmaceutical made up 0.11% of Fortis Capital Advisors's portfolio in Q2 2026, its #164 holding.
  • Fortis Capital Advisors first reported a position in Collegium Pharmaceutical in Q1 2023 and has held it in 7 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Fortis Capital Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.